NCT04521556

Brief Summary

Different modality of anesthesia and analgesia could influence a postoperative quality of recovery (QoR). This study is exploring early QoR after unilateral nephrectomy in the two groups of anesthesia. The first group had a light general anesthesia with thoracic epidural anesthesia and postoperative epidural analgesia with morphine and ropivacaine. The second group had general anesthesia and a continuous postoperative analgesia with tramadol. The postoperative QoR was evaluated 24 hours after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Apr 2019

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2019

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

August 12, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 20, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

September 30, 2021

Status Verified

September 1, 2021

Enrollment Period

2 years

First QC Date

August 12, 2020

Last Update Submit

September 28, 2021

Conditions

Keywords

general anesthesiacombined light general and epidural anesthesiahealth related quality of lifenephrectomy

Outcome Measures

Primary Outcomes (3)

  • Visual analog scale of quality of recovery (QoR)

    Patient rated visual analog scale is a simple scale for rating the quality of recovery by placing "X" on the line. Poor recovery is on the left side of the line. Under the end of the left line is an explanation of poor recovery: in severe pain, nausea \& vomiting, confused, immobilized, unable to eat and unable to communicate. Excellent recovery is on the right side of the line. Under the end of the line is a written explanation: without any pain, comfortable, alert, active, enjoying food and communicating freely.

    24 hours after surgery

  • Quality of recovery 40 (QoR-40)

    The QoR-40 measures five related dimensions of quality of recovery: emotional state (8 items), physical comfort (12 items), physical independence (5 items), psychological support (7 items) and pain (7 items). Each item is rated on a 5 point Likert scale. Minimal possible score is 40 and maximal possible score is 200.

    24 hours after surgery

  • Quality of recovery 15 (QoR-15)

    Quality of recovery (QoR-15) is a short version of QoR - 40 questionnaire. The QoR-15 questionnaire has 15 items scaled from 0 to 10. Minimum score is 0, and maximum 150. It is shorter, user friendly and less time consuming then extensive QoR-40 questionnaire.

    24 hours after surgery

Secondary Outcomes (9)

  • Visual analog scale of pain- at rest and during coughing and straining

    24 hours after surgery

  • Numerical pain scale - at rest and during coughing and straining

    24 hours after surgery

  • Visual pain scale with faces- at rest and during coughing and straining

    24 hours after surgery

  • Visual analog scale of anxiety

    24 hours after surgery

  • Numerical anxiety scale

    24 hours after surgery

  • +4 more secondary outcomes

Study Arms (2)

Epidural anesthesia and analgesia

ACTIVE COMPARATOR

Epidural catheter insertion: Th 9 - Th 10 or Th 10 - Th 11 using the midline approach. Safety of the epidural catheter was confirmed with lidocaine 60 mg. Epidural loading dose was given according to our classification (3,4,5 or 6 ml). Postoperative period in urology high care unit. Epidural analgesia ropivacaine/morphine was administered by a urologist according to our classification (2x2 ml, 2x3 ml and 3x3 ml).

Procedure: Epidural anesthesia with light general anesthesiaProcedure: Postoperative epidural analgesia

Balanced general anesthesia and tramadol analgesia

ACTIVE COMPARATOR

Postoperative period in urology high care unit.

Procedure: General anesthesiaDrug: Continuous intravenous analgesia

Interventions

Epidural anaesthesia: mixture of ropivacaine 6.5 mg/ml and fentanyl 8.3 μg/ml. Light general anesthesia: isoflurane in mixture of 50/50 of nitrous oxide and oxygen to achieve Minimum alveolar concentration between 0.6 and 0.8.

Epidural anesthesia and analgesia

Before the end of operation was given 4 ml of the mixture of ropivacaine 4.4 mg/ml and morphine 0.8mg/ml. Epidural analgesia was continued for next 24 hours with a mixture of ropivacaine 2.2 mg/ml and morphine 0.4 mg/ml.

Also known as: Epidural analgesia with morphine and ropivacaine
Epidural anesthesia and analgesia

Maintaining general anesthesia: nitrous oxide and oxygen in mixture 50/50 and isoflurane to achieve minimum alveolar concentration between 0.8 and 1. Fentanyl loading dose: 6-8 μg/kg. Additional fentanyl doses were given incrementally.

Balanced general anesthesia and tramadol analgesia

Tramadol 100 mg in the first hour followed by tramadol 300 mg continuously for the next 24 hours.

Also known as: Continuous tramadol analgesia
Balanced general anesthesia and tramadol analgesia

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective radical nephrectomy
  • American Society of Anesthesiologists (ASA) physical status classification system: I, II, III

You may not qualify if:

  • Dementia
  • Delirium
  • Acute psychosis
  • Emergent surgery
  • Hospitalisation in Intensive care unit
  • American Society of Anesthesiologists (ASA) physical status classification system: IV
  • Reoperations
  • Muscular diseases
  • Montreal cognitive test \<24 points
  • Contraindications for epidural anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Split

Split, 21000, Croatia

Location

Related Publications (9)

  • Greg Snow (2020) blockrand: Randomization for Block Random Clinical Trials. R package version 1.5. https://CRAN.R-project.org/package=blockrand

    BACKGROUND
  • Stamer UM, Hothker F, Lehnen K, Stuber F. [Postoperative analgesia with tramadol and metamizol. Continual infusion versus patient controlled analgesia]. Anaesthesist. 2003 Jan;52(1):33-41. doi: 10.1007/s00101-002-0427-1. German.

    PMID: 12577163BACKGROUND
  • Myles PS. Measuring quality of recovery in perioperative clinical trials. Curr Opin Anaesthesiol. 2018 Aug;31(4):396-401. doi: 10.1097/ACO.0000000000000612.

    PMID: 29846193BACKGROUND
  • Gornall BF, Myles PS, Smith CL, Burke JA, Leslie K, Pereira MJ, Bost JE, Kluivers KB, Nilsson UG, Tanaka Y, Forbes A. Measurement of quality of recovery using the QoR-40: a quantitative systematic review. Br J Anaesth. 2013 Aug;111(2):161-9. doi: 10.1093/bja/aet014. Epub 2013 Mar 6.

    PMID: 23471753BACKGROUND
  • Myles PS, Weitkamp B, Jones K, Melick J, Hensen S. Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth. 2000 Jan;84(1):11-5. doi: 10.1093/oxfordjournals.bja.a013366.

    PMID: 10740540BACKGROUND
  • Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013 Jun;118(6):1332-40. doi: 10.1097/ALN.0b013e318289b84b.

    PMID: 23411725BACKGROUND
  • Kleif J, Waage J, Christensen KB, Gogenur I. Systematic review of the QoR-15 score, a patient- reported outcome measure measuring quality of recovery after surgery and anaesthesia. Br J Anaesth. 2018 Jan;120(1):28-36. doi: 10.1016/j.bja.2017.11.013. Epub 2017 Nov 22.

    PMID: 29397134BACKGROUND
  • Kleif J, Gogenur I. Severity classification of the quality of recovery-15 score-An observational study. J Surg Res. 2018 May;225:101-107. doi: 10.1016/j.jss.2017.12.040. Epub 2018 Feb 21.

    PMID: 29605019BACKGROUND
  • Cao X, Yumul R, Elvir Lazo OL, Friedman J, Durra O, Zhang X, White PF. A novel visual facial anxiety scale for assessing preoperative anxiety. PLoS One. 2017 Feb 14;12(2):e0171233. doi: 10.1371/journal.pone.0171233. eCollection 2017.

    PMID: 28196099BACKGROUND

MeSH Terms

Conditions

Patient SatisfactionAgnosia

Interventions

Anesthesia, EpiduralAnalgesia, EpiduralMorphineRopivacaineAnesthesia, General

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehaviorPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and AnalgesiaAnalgesiaMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic CompoundsAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Ruben Kovac

    University Hospital Split, Department of Anesthesiology and Intensive Care

    PRINCIPAL INVESTIGATOR
  • Bozidar Duplancic

    University Hospital Split, Department of Anesthesiology and Intensive Care

    STUDY DIRECTOR
  • Verica Ilijev

    University Hospital Split, Department of Anesthesiology and Intensive Care

    STUDY CHAIR
  • Ivo Juginovic

    University Hospital Split, Department of Urology

    STUDY CHAIR
  • Ivan Velat

    University Hospital Split,Department of Urology

    STUDY CHAIR
  • Hrvoje Vucemilovic

    University Hospital Split, Department of Anesthesiology and Intensive Care

    STUDY CHAIR
  • Svjetlana Dosenovic

    University Hospital Split, Department of Anesthesiology and Intensive Care

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 12, 2020

First Posted

August 20, 2020

Study Start

April 1, 2019

Primary Completion

April 1, 2021

Study Completion

June 1, 2021

Last Updated

September 30, 2021

Record last verified: 2021-09

Locations